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httcense.Abstract Objective: This study aimed to evaluate the value of gadolinium-enhanced dynamic MR
imaging for differentiating benign and malignant parotid gland tumors, and for characterizing the
various histological types.
Patients and methods: Non-enhanced T1-weighted (T1-W), fat-suppressed T2-weighted (T2-W),
and gadolinium-enhanced fat-suppressed dynamic T1-weighted images were obtained preopera-
tively in 27 patients (28 parotid gland tumors), by using a 1.5 or 3 T MR imaging unit (GE, Signa
Exite). The tumor margins and the enhancement curve patterns on dynamic MR imaging were ana-
lyzed. All patients underwent a parotidectomy with histopathologic analysis.
Results: Pleomorphic adenomas depict a gradual enhancement pattern. Warthin’s tumors depict
an early peak of enhancement and a high washout pattern. Malignant tumors depict an early peak
of enhancement and a low washout pattern.
Conclusion: Gadolinium-enhanced dynamic MR imaging improved the performance of MR imag-
ing in differentiating benign from malignant parotid gland tumors and characterizing the different
histological types of benign tumors.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
It is clinically important to determinewhether a salivary gland tu-
mor is benign or malignant preoperatively, because this informa-10109902.
il.com, ghadagouhar@yahoo.
tian Society of Radiology and
g by Elsevier
ing by Elsevier B.V. on behalf of E
p://dx.doi.org/10.1016/j.ejrnm.2013tion strongly inﬂuences the surgical procedure. Local excision or
superﬁcial parotidectomy is performed to treat benign tumors,
whereas total parotidectomy with or without removal of the fa-
cial nerve tissue is performed to treat malignant tumors (1). Pre-
operative aspiration cytology is a minimally invasive procedure;
however, the results are not always conclusive because insufﬁ-
cient specimens are sometimes obtained owing to a small sample
size or the deep location of the tumor (2). Moreover, intraopera-
tive frozen section analysis in patients with parotid carcinoma is
signiﬁcantly superior to the aspiration cytology (3). Therefore,
preoperative imaging has an important role in surgical planning.
The static MR imaging characteristics of malignant salivary
gland tumors are reportedly irregular tumor margin, signalgyptian Society of Radiology and Nuclear Medicine.
.02.007
Table 1 Histopathologic diagnoses of parotid gland tumors.
Diagnosis No. of lesions
Benign (n = 18)
Pleomorphic adenoma 12
Warthin’s tumor 6
Malignant (n = 10)
Mucoepidermoid carcinoma 6
Adenoid cystic carcinoma 3
Carcinoma ex pleomorphic adenoma 1
Table 2 TIC patterns (A, B, C) among histopathologic
diagnoses.
Diagnosis TIC patterns
A B C
Benign (n = 18)
Pleomorphic adenoma (n= 12) 12
Warthin’s tumor (n= 6) 6
Malignant (n = 10)
Mucoepidermoid carcinoma (n= 6) 6
Adenoid cystic carcinoma (n= 3) 3
Carcinoma ex pleomorphic adenoma (n= 1) 1
204 H.M. El Shahat et al.intensity heterogeneity, and tumor inﬁltration into the sur-
rounding tissue (4–6). Freling et al. (7) reported that tumormar-
gins, and signal intensity were not discriminative factors to
predict benign or malignant disease. Inﬁltration into deep struc-
tures was observed only in patients with malignant tumors.
Thus, the role of static MR imaging in the differentiation of be-
nign andmalignant salivary gland tumors appears to be contro-
versial, except with regard to inﬁltration into deep structures.
The purpose of our study was to evaluate the diagnostic va-
lue of gadolinium-enhanced dynamic MR imaging for differ-
entiating benign and malignant parotid gland tumors, and
for characterizing the various histological types (pleomorphic
adenoma, Warthin’s tumor and malignant tumors).
2. Patients and methods
This study involved 28 parotid gland tumors (Table 1) in 27
patients (17 woman, 10 men; age range 32–71 years). All pa-
tients had undergone pathological examination. The distribu-
tions of benign and malignant tumors are shown in Table 1.
All MR imaging examinations were performed using a 1.5 or
3 T imaging unit (GE, Signa Exite). Non-enhanced T1-weighted
(T1-W), fat-suppressed T2-weighted (T2-W), and gadolinium-
enhanced fat-suppressed dynamic T1-weighted images were ob-
tained for all patients. The section that included the maximum
diameter of the tumorwas selected for dynamic imaging. Fifteen
acquisitions of 11 s scan time each were performed (total acqui-
sition time 2.5 min). The region of interest for signal intensity
measurement was approximately 3–4 mm in diameter in most
cases. Thereafter, time-signal intensity curve (TIC) was ob-
tained for all tumors. Three characteristic TICs were observed.
TIC parameters include T peak (time of peak enhancement) and
WR (washout ratio). In type A, TIC tumor type, the T peak was
longer than 120 s. This was considered a gradual enhancement.
In type B, TIC tumor type, the T peak was shorter than or equal
to 120 s and theWRwas greater than or equal to 30%. This was
considered as early enhancement and high washout. In type C,
TIC tumor type, the T peak was shorter than or equal to 120 s
and theWRwas less than 30%. A parotid gland tumor with this
pattern was considered to have early enhancement and low
washout. The TIC type of each parotid gland tumor was deter-
mined before surgery in all patients. Finally, all MR imaging
examinations togetherwith the tumor speciﬁc curveswere corre-
lated with the histopathologic diagnosis.
3. Results
All tumors with a T peak longer than 120 s were benign, and
tumors with a T peak shorter than 120 s were either benignor malignant. We chose 120 s as the cutoff T peak to maximize
accuracy. To distinguish malignant from benign lesions, we
chose 30% as the cutoff WR on the basis of the high accuracy
measure. (Table 2) shows the distributions of benign and
malignant tumors among the three TIC tumor types. Pleomor-
phic adenomas depict gradual enhancement pattern, (type A)
TIC (Fig. 1). Warthin’s tumors depict an early peak of
enhancement and a high washout pattern, (type B) TIC
(Fig. 2). Malignant tumors depict an early peak of enhance-
ment and low washout pattern, (type C) TIC (Fig. 3).
4. Discussion
The therapeutic strategy for a parotid mass includes identiﬁca-
tion of the mass by sonography, CT, MRI, or nuclear medi-
cine, and histological diagnosis through biopsy (8).
Preoperative diagnosis of parotid gland tumors plays an
important role in surgical planning because surgeons use a
more aggressive approach to treat malignant tumors (9).
Among parotid masses, pleomorphic adenoma accounts for
about 70% of all lesions and the next most common is War-
thin’s tumor. Pleomorphic adenomas have malignant potential.
It has been established that nearly 25% of all pleomorphic ade-
nomas may eventually become malignant if not treated. There-
fore, pleomorphic adenomas must be completely resected. In
contrast, malignant change is extremely rare in Warthin’s
tumors, so it is clinically important to make a diagnosis of this
tumor (10).
The surgery chosen for the treatment of parotid gland tu-
mors depends on the location and histologic type of the tumor
(11).
The treatment plan differs slightly depending on whether
the tumor is a pleomorphic adenoma or a Warthin’s tumor.
Superﬁcial parotidectomy with preservation of the facial nerve
or partial superﬁcial parotidectomy is recommended in
patients with pleomorphic adenoma, whereas enucleation or
superﬁcial parotidectomy with preservation of the facial nerve
is adapted for patients with a Warthin’s tumor (12–14).
When the tumor is malignant, total parotidectomy is se-
lected and the facial nerve may be sacriﬁced. Therefore, preop-
erative differentiation between benign and malignant tumors is
very important (8).
The results of preoperative aspiration cytology are some-
times inconclusive or false. Thus, the ability to predict the exis-
tence of benign or malignant tumors on the basis of imaging
ﬁndings would be very useful (15).
Fig. 1 Pleomorphic adenoma of the left parotid gland in a 39-year-old woman. (a) Transverse T1-weighted spin-echo MR image shows a
well deﬁned hypointense mass in the left parotid gland. (b) Transverse T2-weighted fast spin-echo MR image shows a hyperintense mass.
(c) Transverse T1-weighted spin-echo MR image obtained 120 s after contrast material administration shows moderate tumor
enhancement. (d) Transverse T1-weighted spin-echo MR image obtained 300 s after contrast material administration shows gradual tumor
enhancement. (e) TIC and corresponding transverse T1-weighted spin-echo MR image depict gradual enhancement pattern (type A). The
round cursor marks the region of interest selected for signal intensity measurement at dynamic MR imaging.
Fig. 2 Warthin’s tumor of the right parotid gland in a 57-year-old woman. (a) Transverse T1-weighted spin-echo MR image shows a low
signal intensity mass in the right parotid gland. (b) Transverse T1-weighted spin-echo MR image obtained 60 s after contrast material
administration shows early enhancement. (c) Transverse T1-weighted spin-echo MR image obtained 300 s after contrast material
administration shows washout enhancement. (d) TIC and corresponding transverse T1-weighted spin-echo MR image depict an early peak
of enhancement and a high washout pattern (type B). The round cursor marks the region of interest selected for signal intensity
measurement at dynamic MR imaging.
Diagnostic value of gadolinium-enhanced dynamic MR imaging for parotid gland tumors 205
Fig. 3 Mucoepidermoid carcinoma of the right parotid gland in a 56-year-old man. (a) Transverse T1-weighted spin-echo MR image
shows a well deﬁned hypointense massin the right parotid gland. (b) Transverse T2-weighted spin-echo MR image shows slightly
heterogenous hyperintense mass. (c) Transverse T1-weighted spin-echo MR image obtained 60 s after contrast material administration
shows early enhancement. (d) Transverse T1-weighted spin-echo MR image obtained 300 s after contrast material administration shows
delayed washout. (e) TIC and corresponding transverse T1-weighted spin-echo MR image depict an early peak of enhancement and a low
washout pattern (type c). The round cursor marks the region of interest selected for signal intensity measurement at dynamic MR imaging.
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gland tumors are irregular tumor margin, signal intensity
heterogeneity, tumor inﬁltration into surrounding tissue, and
low signal intensity on T2-weighted images, although there
was some overlap (16–18). Thus, the role of static MR imaging
in the differentiation of benign and malignant parotid gland
tumors appears to be controversial.
The aim of this study was to assess the possibility of diag-
nosing parotid masses by imaging alone, using gadolinium-en-
hanced dynamic MR imaging.
Takashima et al. (19) reported the results of performing dy-
namic MR imaging in the evaluation of head and neck lesions.
They examined 43 parotid gland lesions by using dynamic MR
imaging and assigned the lesions to ﬁve groups according to
the type of TIC: type A, curve peaks 0–30 s after contrast
material administration; type B, curve peaks at 30–608 s; type
C, curve peaks at 60–120 s; type D, gradual upward slope; and
type E, ﬂat. These authors classiﬁed tumors according to
Tpeak only. According to their results, only 4 of 21 pleomor-
phic adenomas showed an early enhancement peak at fewer
than 60 s after contrast material administration; 8 of 10 War-
thin’s tumors showed a peak at fewer than 60 s; and 5 of 11
malignant tumors showed gradual enhancement.
Yabuuchi et al. (15) examined 25 parotid gland lesions
using dynamic MR imaging. Their results appear to be consis-
tent with those of Takashima et al. (19) in terms of the long
Tpeak for pleomorphic adenomas and the short Tpeak for
Warthin’s tumors, but different from their results in terms of
the Tpeak values for malignant tumors.
Tsushima et al. (20) examined 18 parotid gland tumors by
using dynamic MR imaging. According to their results, sevenpleomorphic adenomas and two adenoid cystic carcinomas
showed gradual enhancement during the ﬁrst 260 s after
contrast material administration; seven Warthin’s tumors
showed rapid enhancement during the ﬁrst 20 s and then a de-
crease in signal intensity. The other malignant tumors showed a
rapid increase in signal intensity during the ﬁrst 20 s and then a
gradual decrease or increase in signal intensity.
Takashima et al. (19) concluded that dynamic MR imaging
contributes little to the prediction of malignancy but can help
narrow the differential diagnosis and is potentially useful in
determining tumor vascularity.
Tsushima et al. (20) concluded that dynamic MR imaging
could help distinguish pleomorphic adenoma from the War-
thin’s tumor but not pleomorphic adenoma from adenoid cys-
tic carcinoma or Warthin’s tumor from other malignant
tumors. Both Takashima et al. (19) and Tsushima et al. (20)
reports, focused on the Tpeak for parotid gland tumors.
Yabuuchi et al. (15) analyzed other TIC parameters as well
as the Tpeak and correlated these parameters with histopatho-
logic ﬁndings. According to their results, Tpeak correlated clo-
sely with microvessel count and the WR accurately reﬂected
the cellularity-stromal grade. The microvessel count is consid-
ered to represent tumor vascularity, and the Tpeak will be
short if the microvessel count is high. The WR depends on
the difference in the amount of contrast material within the tu-
mor between the intravascular and extravascular phases. A
large extracellular space with ﬁbrous stroma retains contrast
material for a certain period. Therefore, tumors with a high
cellularity-stromal grade will retain less contrast material and
have a high WR, whereas those with a low cellularity-stromal
grade will have a low WR.
Diagnostic value of gadolinium-enhanced dynamic MR imaging for parotid gland tumors 207In our study, we analyzed Tpeak and WR, and according to
the results of our study, a Tpeak of 120 s enabled the
differentiation of pleomorphic adenomas from malignant
tumors. Assessment of the Tpeak alone did not enable differ-
entiation of Warthin’s tumors from malignant tumors. The
WR for Warthin’s tumours were higher than those for the
malignant tumors. Therefore, the combined assessment of
Tpeak and WR enabled the differentiation of pleomorphic
adenomas, Warthin’s tumors and malignant tumors. TIC
types’ classiﬁcation according to Tpeak and WR had similar
results to Yabuuchi et al. (15).
We conclude that the Tpeak and WR derived from TICs at
gadolinium-enhanced dynamic MR imaging shows high value
in the characterization of parotid gland tumors. A long Tpeak
for pleomorphic adenomas, a short Tpeak and high WR for
Warthin’s tumors and a short Tpeak and low WR for malig-
nant tumors were observed in most instances.
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